Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario
May 1, 2013, 00:00
10.1016/j.jval.2013.03.696
https://www.valueinhealthjournal.com/article/S1098-3015(13)00767-5/fulltext
Title :
Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00767-5&doi=10.1016/j.jval.2013.03.696
First page :
A142
Section Title :
Cancer
Open access? :
No
Section Order :
246